endolysin has been researched along with Disease Models, Animal in 11 studies
lysine-4,4,5,5-d4 : A deuterated compound that is lysne in which the methylene hydrogens at positions 4, 4, 5 and 5 have been replaced by deuterium.
Disease Models, Animal: Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The treatment of endophthalmitis is becoming very challenging due to the emergence of multidrug-resistant bacteria." | 5.40 | Intravitreal injection of the chimeric phage endolysin Ply187 protects mice from Staphylococcus aureus endophthalmitis. ( Donovan, DM; Kumar, A; Singh, PK, 2014) |
| "Treatment of localized burn wound infection with combination therapy resulted in early resolution of infection followed by fast healing." | 1.43 | Potential of combination therapy of endolysin MR-10 and minocycline in treating MRSA induced systemic and localized burn wound infections in mice. ( Chhibber, S; Chopra, S; Harjai, K, 2016) |
| "The treatment of endophthalmitis is becoming very challenging due to the emergence of multidrug-resistant bacteria." | 1.40 | Intravitreal injection of the chimeric phage endolysin Ply187 protects mice from Staphylococcus aureus endophthalmitis. ( Donovan, DM; Kumar, A; Singh, PK, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 8 (72.73) | 24.3611 |
| 2020's | 3 (27.27) | 2.80 |
| Authors | Studies |
|---|---|
| Eichenseher, F | 2 |
| Herpers, BL | 1 |
| Badoux, P | 1 |
| Leyva-Castillo, JM | 1 |
| Geha, RS | 1 |
| van der Zwart, M | 1 |
| McKellar, J | 1 |
| Janssen, F | 1 |
| de Rooij, B | 1 |
| Selvakumar, L | 1 |
| Röhrig, C | 1 |
| Frieling, J | 1 |
| Offerhaus, M | 1 |
| Loessner, MJ | 2 |
| Schmelcher, M | 3 |
| Fraga, AG | 1 |
| Trigo, G | 1 |
| Murthy, RK | 1 |
| Akhtar, S | 1 |
| Hebbur, M | 1 |
| Pacheco, AR | 1 |
| Dominguez, J | 1 |
| Silva-Gomes, R | 1 |
| Gonçalves, CM | 1 |
| Oliveira, H | 1 |
| Castro, AG | 1 |
| Sharma, U | 1 |
| Azeredo, J | 1 |
| Pedrosa, J | 1 |
| Fursov, MV | 1 |
| Abdrakhmanova, RO | 1 |
| Antonova, NP | 1 |
| Vasina, DV | 1 |
| Kolchanova, AD | 1 |
| Bashkina, OA | 1 |
| Rubalsky, OV | 1 |
| Samotrueva, MA | 1 |
| Potapov, VD | 1 |
| Makarov, VV | 1 |
| Yudin, SM | 1 |
| Gintsburg, AL | 1 |
| Tkachuk, AP | 1 |
| Gushchin, VA | 1 |
| Rubalskii, EO | 1 |
| Fujimoto, K | 1 |
| Kimura, Y | 1 |
| Shimohigoshi, M | 1 |
| Satoh, T | 1 |
| Sato, S | 1 |
| Tremmel, G | 1 |
| Uematsu, M | 1 |
| Kawaguchi, Y | 1 |
| Usui, Y | 1 |
| Nakano, Y | 1 |
| Hayashi, T | 1 |
| Kashima, K | 1 |
| Yuki, Y | 1 |
| Yamaguchi, K | 1 |
| Furukawa, Y | 1 |
| Kakuta, M | 1 |
| Akiyama, Y | 1 |
| Yamaguchi, R | 1 |
| Crowe, SE | 1 |
| Ernst, PB | 1 |
| Miyano, S | 1 |
| Kiyono, H | 1 |
| Imoto, S | 1 |
| Uematsu, S | 1 |
| Doehn, JM | 1 |
| Fischer, K | 1 |
| Reppe, K | 1 |
| Gutbier, B | 1 |
| Tschernig, T | 1 |
| Hocke, AC | 1 |
| Fischetti, VA | 1 |
| Löffler, J | 1 |
| Suttorp, N | 1 |
| Hippenstiel, S | 1 |
| Witzenrath, M | 1 |
| Singh, PK | 1 |
| Donovan, DM | 3 |
| Kumar, A | 1 |
| Shen, Y | 1 |
| Nelson, DC | 1 |
| Eugster, MR | 1 |
| Hanke, DC | 1 |
| Dong, S | 1 |
| Pritchard, DG | 1 |
| Lee, JC | 1 |
| Becker, SC | 1 |
| Foster-Frey, J | 1 |
| Powell, AM | 1 |
| Camp, MJ | 1 |
| Pohl, CS | 1 |
| Tang, F | 1 |
| Li, D | 1 |
| Wang, H | 1 |
| Ma, Z | 1 |
| Lu, C | 1 |
| Dai, J | 1 |
| Chopra, S | 1 |
| Harjai, K | 1 |
| Chhibber, S | 1 |
| Jun, SY | 1 |
| Jung, GM | 1 |
| Yoon, SJ | 1 |
| Oh, MD | 1 |
| Choi, YJ | 1 |
| Lee, WJ | 1 |
| Kong, JC | 1 |
| Seol, JG | 1 |
| Kang, SH | 1 |
11 other studies available for endolysin and Disease Models, Animal
| Article | Year |
|---|---|
Linker-Improved Chimeric Endolysin Selectively Kills Staphylococcus aureus
Topics: Animals; Anti-Bacterial Agents; Cellulitis; Disease Models, Animal; Endopeptidases; Epidermis; Human | 2022 |
Antimicrobial activity of Mycobacteriophage D29 Lysin B during Mycobacterium ulcerans infection.
Topics: Animals; Bacteriolysis; Buruli Ulcer; Disease Models, Animal; Endopeptidases; Female; Interferon-gam | 2019 |
Antibiofilm Activity of a Broad-Range Recombinant Endolysin LysECD7: In Vitro and In Vivo Study.
Topics: Animals; Anti-Bacterial Agents; Biofilms; Coliphages; Disease Models, Animal; Drug Resistance, Multi | 2020 |
Metagenome Data on Intestinal Phage-Bacteria Associations Aids the Development of Phage Therapy against Pathobionts.
Topics: Animals; Anti-Bacterial Agents; Bacteriophages; Clostridioides difficile; Clostridium Infections; Di | 2020 |
Delivery of the endolysin Cpl-1 by inhalation rescues mice with fatal pneumococcal pneumonia.
Topics: Administration, Inhalation; Animals; Anti-Bacterial Agents; Bacterial Load; Bacteriophages; Biologic | 2013 |
Intravitreal injection of the chimeric phage endolysin Ply187 protects mice from Staphylococcus aureus endophthalmitis.
Topics: Animals; Biofilms; Coliphages; Cytokines; Disease Models, Animal; Electroretinography; Endopeptidase | 2014 |
Evolutionarily distinct bacteriophage endolysins featuring conserved peptidoglycan cleavage sites protect mice from MRSA infection.
Topics: Animals; Anti-Bacterial Agents; Bacteremia; Bacteriophages; Biological Therapy; Cell Wall; Disease M | 2015 |
Synergistic streptococcal phage λSA2 and B30 endolysins kill streptococci in cow milk and in a mouse model of mastitis.
Topics: Animals; Bacterial Load; Calcium; Cattle; Disease Models, Animal; Drug Synergism; Endopeptidases; Fe | 2015 |
Prophage lysin Ply30 protects mice from Streptococcus suis and Streptococcus equi subsp. zooepidemicus infections.
Topics: Animal Structures; Animals; Anti-Bacterial Agents; Bacteriolysis; Blood; Colony Count, Microbial; Di | 2015 |
Potential of combination therapy of endolysin MR-10 and minocycline in treating MRSA induced systemic and localized burn wound infections in mice.
Topics: Administration, Oral; Animal Structures; Animals; Anti-Bacterial Agents; Bacterial Load; Burns; Dise | 2016 |
Antibacterial properties of a pre-formulated recombinant phage endolysin, SAL-1.
Topics: Animals; Anti-Bacterial Agents; Chemistry, Pharmaceutical; Chromatography, Liquid; Disease Models, A | 2013 |